Medium-term health-related quality of life in patients with pulmonary arterial hypertension treated with goal-oriented sequential combination therapy based on exercise capacity.
Hirashiki, Akihiro; Adachi, Shiro; Okumura, Naoki; Nakano, Yoshihisa; Shimokata, Shigetake; Shimizu, Atsuya; Arai, Hidenori; Toba, Kenji; Murohara, Toyoaki; Kondo, Takahisa.
Health Qual Life Outcomes
; 17(1): 103, 2019 Jun 14.
Artigo em Inglês | MEDLINE | ID: mdl-31200710
Phosphodiesterase 5 inhibitors for pulmonary hypertension.
Prevalence of Anxiety and Depression in Pulmonary Hypertension and Changes during Therapy.
Quality of life as a prognostic marker in pulmonary arterial hypertension.
Pulmonary hypertension: Molecular aspects of current therapeutic intervention and future direction.
Drug-induced pulmonary arterial hypertension: a primer for clinicians and scientists.
Wspólczesna farmakoterapia tetniczego nadcisnienia plucnego.
Global research trends in the medical therapy of pulmonary arterial hypertension 2000-2014.
Novel strategies for treatment of pulmonary arterial hypertension.
Targeted Treatments for Pulmonary Arterial Hypertension: Interpreting Outcomes by Network Meta-analysis.
Pulmonary arterial hypertension: a current review of pharmacological management.